Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Development of Antimicrobial Peptides from Amphibian"
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antimicrobial Peptides".
Deadline for manuscript submissions: closed (30 June 2020) | Viewed by 25738
Special Issue Editors
Interests: antimicrobial peptides; peptide-membrane interaction; cystic fibrosis; infectious diseases; pneumonia; keratitis; drug development; wound healing; Pseudomonas aeruginosa
Interests: bioactive peptides; biological/biochemical characterization of small bioactive molecules; natural products; structure-activity relationship of natural/synthetic bioactive molecules
Special Issue Information
Since 1987, when Michael Zasloff isolated magainins from skin secretions of the African toad Xenopus laevis, an increasing number of antimicrobial peptides (AMPs) have been identified in different anuran species and studied in detail. As a result, frog skin is now known as one of the richest sources of natural AMPs from different families. In addition to their originally discovered role as key effectors of innate immunity with a primary role in protecting the host from invading noxious microorganisms, they are now known to carry out functions related to host immune modulation, e.g., endotoxin neutralization, chemotaxis, and wound healing activity. Several studies have emphasized the potential for AMPs to be used in the development of new anti-infective agents with expanding properties. Furthermore, in the rapid evolving field of nanotechnology, several approaches have been designed and developed to conjugate the AMPs with nanoparticulate systems to assist peptide delivery to target sites, thus minimizing potential side effects.
This Special Issue aims to present the most recent advances in the development of frog-skin AMPs as alternative compounds to fight against the alarming problem of antibiotic resistance and to be used in clinical settings.Prof. Dr. Maria Luisa Mangoni
Dr. Bruno Casciaro
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- antimicrobial peptides
- multidrug resistance